Vitamin D supplementation during pregnancy: Double‐blind, randomized clinical trial of safety and effectiveness

The need, safety, and effectiveness of vitamin D supplementation during pregnancy remain controversial. In this randomized, controlled trial, women with a singleton pregnancy at 12 to 16 weeks' gestation received 400, 2000, or 4000 IU of vitamin D3 per day until delivery. The primary outcome was maternal/neonatal circulating 25‐hydroxyvitamin D [25(OH)D] concentration at delivery, with secondary outcomes of a 25(OH)D concentration of 80 nmol/L or greater achieved and the 25(OH)D concentration required to achieve maximal 1,25‐dihydroxyvitamin D3 [1,25(OH)2D3] production. Of the 494 women enrolled, 350 women continued until delivery: Mean 25(OH)D concentrations by group at delivery and 1 month before delivery were significantly different (p < 0.0001), and the percent who achieved sufficiency was significantly different by group, greatest in 4000‐IU group (p < 0.0001). The relative risk (RR) for achieving a concentration of 80 nmol/L or greater within 1 month of delivery was significantly different between the 2000‐ and the 400‐IU groups (RR = 1.52, 95% CI 1.24–1.86), the 4000‐ and the 400‐IU groups (RR = 1.60, 95% CI 1.32–1.95) but not between the 4000‐ and. 2000‐IU groups (RR = 1.06, 95% CI 0.93–1.19). Circulating 25(OH)D had a direct influence on circulating 1,25(OH)2D3 concentrations throughout pregnancy (p < 0.0001), with maximal production of 1,25(OH)2D3 in all strata in the 4000‐IU group. There were no differences between groups on any safety measure. Not a single adverse event was attributed to vitamin D supplementation or circulating 25(OH)D levels. It is concluded that vitamin D supplementation of 4000 IU/d for pregnant women is safe and most effective in achieving sufficiency in all women and their neonates regardless of race, whereas the current estimated average requirement is comparatively ineffective at achieving adequate circulating 25(OH)D concentrations, especially in African Americans. © 2011 American Society for Bone and Mineral Research

[1]  C. Gordon,et al.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[2]  C. Wagner,et al.  Maternal vitamin D and fetal growth in early-onset severe preeclampsia. , 2011, American journal of obstetrics and gynecology.

[3]  M. Rovers,et al.  Cord Blood Vitamin D Deficiency Is Associated With Respiratory Syncytial Virus Bronchiolitis , 2011, Pediatrics.

[4]  Xiaoran Zhang,et al.  Cord blood vitamin D status impacts innate immune responses. , 2011, The Journal of clinical endocrinology and metabolism.

[5]  M. Cantorna,et al.  Epigenetic Reduction in Invariant NKT Cells following In Utero Vitamin D Deficiency in Mice , 2011, The Journal of Immunology.

[6]  C. Camargo,et al.  Cord-Blood 25-Hydroxyvitamin D Levels and Risk of Respiratory Infection, Wheezing, and Asthma , 2011, Pediatrics.

[7]  M. Hewison.  Vitamin D and the immune system: new perspectives on an old theme. , 2010, Endocrinology and metabolism clinics of North America.

[8]  P. Dhawan,et al.  Evidence for a role of prolactin in calcium homeostasis: regulation of intestinal transient receptor potential vanilloid type 6, intestinal calcium absorption, and the 25-hydroxyvitamin D(3) 1alpha hydroxylase gene by prolactin. , 2010, Endocrinology.

[9]  S. Sereika,et al.  Lactation and bone turnover: a conundrum of marked bone loss in the setting of coupled bone turnover. , 2010, The Journal of clinical endocrinology and metabolism.

[10]  C. Wagner,et al.  Analyzing Adherence to Prenatal Supplement: Does Pill Count Measure Up? , 2010, International journal of endocrinology.

[11]  G. Cheng,et al.  Convergence of IL-1β and VDR Activation Pathways in Human TLR2/1-Induced Antimicrobial Responses , 2009, PloS one.

[12]  T. Down,et al.  Placenta-specific Methylation of the Vitamin D 24-Hydroxylase Gene , 2009, Journal of Biological Chemistry.

[13]  S Robinson,et al.  Vitamin D deficiency and supplementation during pregnancy , 2009, Clinical endocrinology.

[14]  Y. Zhong,et al.  Calcitonin, a Regulator of the 25-Hydroxyvitamin D3 1α-Hydroxylase Gene* , 2009, Journal of Biological Chemistry.

[15]  A. Gombart,et al.  Vitamin D-Directed Rheostatic Regulation of Monocyte Antibacterial Responses1 , 2009, The Journal of Immunology.

[16]  H. Bauchner,et al.  Association between vitamin D deficiency and primary cesarean section. , 2009, The Journal of clinical endocrinology and metabolism.

[17]  C. Wagner,et al.  Prevention of Rickets and Vitamin D Deficiency in Infants, Children, and Adolescents , 2008, Pediatrics.

[18]  B. Hollis,et al.  25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. , 2008, The American journal of clinical nutrition.

[19]  T. Nakahata,et al.  Craniotabes in normal newborns: the earliest sign of subclinical vitamin D deficiency. , 2008, The Journal of clinical endocrinology and metabolism.

[20]  J. Adams,et al.  Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity , 2008, Nature Clinical Practice Endocrinology &Metabolism.

[21]  Michael J. Pencina,et al.  Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.

[22]  B. Larijani,et al.  Correlation between vitamin D3 deficiency and insulin resistance in pregnancy , 2008, Diabetes/metabolism research and reviews.

[23]  Lisa M Bodnar,et al.  Maternal vitamin D deficiency increases the risk of preeclampsia. , 2007, The Journal of clinical endocrinology and metabolism.

[24]  A. Mackay-Sim,et al.  Maternal vitamin D depletion alters neurogenesis in the developing rat brain , 2007, International Journal of Developmental Neuroscience.

[25]  P. Arora,et al.  Vitamin D supplementation for non-Western pregnant women: the British experience. , 2007, The American journal of clinical nutrition.

[26]  M. Georgieff.  Nutrition and the developing brain: nutrient priorities and measurement. , 2007, The American journal of clinical nutrition.

[27]  J. Adams.  Vitamin D as a defensin. , 2006, Journal of musculoskeletal & neuronal interactions.

[28]  G. Tenderich,et al.  Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. , 2006, The American journal of clinical nutrition.

[29]  J. Adams,et al.  Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response , 2006, Science.

[30]  R. Koerfer,et al.  Vitamin D insufficiency in congestive heart failure: Why and what to do about it? , 2006, Heart Failure Reviews.

[31]  R. Vieth,et al.  Effect of vitamin D replacement on musculoskeletal parameters in school children: a randomized controlled trial. , 2006, The Journal of clinical endocrinology and metabolism.

[32]  C. Wagner,et al.  Normal serum vitamin D levels. , 2005, The New England journal of medicine.

[33]  B. Hollis.  Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. , 2005, The Journal of nutrition.

[34]  Demet Toprak,et al.  Vitamin D deficiency in early infancy. , 2005, The Journal of nutrition.

[35]  J. McGrath,et al.  Distribution of the Vitamin D receptor and 1α-hydroxylase in human brain , 2005, Journal of Chemical Neuroanatomy.

[36]  C. Wagner,et al.  Vitamin D requirements during lactation: high-dose maternal supplementation as therapy to prevent hypovitaminosis D for both the mother and the nursing infant. , 2004, The American journal of clinical nutrition.

[37]  S. Ladhani,et al.  Presentation of vitamin D deficiency , 2004, Archives of Disease in Childhood.

[38]  C. Wagner,et al.  Assessment of dietary vitamin D requirements during pregnancy and lactation. , 2004, The American journal of clinical nutrition.

[39]  G. Plotnikoff,et al.  Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. , 2003, Mayo Clinic proceedings.

[40]  D. Eyles,et al.  1,25-Dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons , 2003, Neuroscience Letters.

[41]  A. Mackay-Sim,et al.  Vitamin d3 and brain development , 2003, Neuroscience.

[42]  Cecilia A. Hale,et al.  Calcium Absorption Varies within the Reference Range for Serum 25-Hydroxyvitamin D , 2003, Journal of the American College of Nutrition.

[43]  M. Anatoliotaki,et al.  Congenital rickets due to maternal vitamin D deficiency in a sunny island of Greece , 2003, Acta paediatrica.

[44]  M. Zaidi,et al.  Calcitonin and bone formation: a knockout full of surprises. , 2002, The Journal of clinical investigation.

[45]  M. Alfaham,et al.  Vitamin D deficiency in pregnant women from a non‐European ethnic minority population—an interventional study , 2002, BJOG : an international journal of obstetrics and gynaecology.

[46]  F. Aboitiz,et al.  [Williams syndrome: clinical, cytogenetical, neurophysiological and neuroanatomic study]. , 2002, Revista medica de Chile.

[47]  B. Boyan,et al.  Membrane mediated signaling mechanisms are used differentially by metabolites of vitamin D3 in musculoskeletal cells , 2002, Steroids.

[48]  G. Giaccone,et al.  Circulating Vα24+ Vβ11+ NKT Cell Numbers Are Decreased in a Wide Variety of Diseases That Are Characterized by Autoreactive Tissue Damage , 2001 .

[49]  R. Vieth,et al.  Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. , 2001, The American journal of clinical nutrition.

[50]  R. Mathias.  Rickets in an infant with Williams syndrome , 2000, Pediatric Nephrology.

[51]  F. Larrea,et al.  Preeclampsia is associated with low circulating levels of insulin-like growth factor I and 1,25-dihydroxyvitamin D in maternal and umbilical cord compartments. , 2000, The Journal of clinical endocrinology and metabolism.

[52]  J. MacMillan,et al.  Familial occurrence of idiopathic infantile hypercalcemia , 1999, Pediatric Nephrology.

[53]  H. DeLuca,et al.  Calcitonin is a major regulator for the expression of renal 25-hydroxyvitamin D3-1alpha-hydroxylase gene in normocalcemic rats. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[54]  B. Hollis,et al.  Quantification of circulating 1,25-dihydroxyvitamin D by radioimmunoassay with 125I-labeled tracer. , 1996, Clinical chemistry.

[55]  S E Whitmore,et al.  Vitamin D deficiency in homebound elderly persons. , 1996, JAMA.

[56]  C. Hales,et al.  Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in East London Asians , 1995, Diabetologia.

[57]  R. Sinha,et al.  Determinants of plasma vitamin E in healthy males. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[58]  B. Hollis,et al.  Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. , 1993, Clinical chemistry.

[59]  R. Klein,et al.  A diet history questionnaire ranks nutrient intakes in middle-aged and older men and women similarly to multiple food records. , 1993, The Journal of nutrition.

[60]  R. Mason,et al.  Immunonephelometric assay of vitamin D-binding protein. , 1992, Clinical chemistry.

[61]  G Block,et al.  Comparison of two dietary questionnaires validated against multiple dietary records collected during a 1-year period. , 1992, Journal of the American Dietetic Association.

[62]  K. Błażewska,et al.  [A case of idiopathic hypercalcemia (hypersensitivity to vitamin D 3]. , 1992, Wiadomosci lekarskie.

[63]  E W Gunter,et al.  An evaluation of a food frequency questionnaire for assessing dietary intake of specific carotenoids and vitamin E among low-income black women. , 1991, American journal of epidemiology.

[64]  G. Koch,et al.  The Application of the Principle of Intention–to–Treat to the Analysis of Clinical Trials , 1991 .

[65]  R. Vieth.  The mechanisms of vitamin D toxicity. , 1990, Bone and mineral.

[66]  R. Wallace,et al.  The relationship of 1,25-dihydroxyvitamin D and radial bone mass. , 1990, Bone and mineral.

[67]  J. Squifflet,et al.  INFANTS AND VERY YOUNG CHILDREN AS KIDNEY DONORS , 1989, The Lancet.

[68]  G Block,et al.  Validation of a retrospective questionnaire assessing diet 10-15 years ago. , 1989, American journal of epidemiology.

[69]  L. Akslen,et al.  Elevated 1,25‐dihydroxyvitamin D and normocalcaemia in presumed familial Williams syndrome , 1987, Clinical genetics.

[70]  T. Koivula,et al.  Maternal compared with infant vitamin D supplementation. , 1986, Archives of disease in childhood.

[71]  B. Gügi,et al.  Vitamin D Supplementation in Pregnancy: A Controlled Trial of Two Methods , 1986, Obstetrics and gynecology.

[72]  F. Glorieux,et al.  Vitamin D supplementation during pregnancy: effect on neonatal calcium homeostasis. , 1986, The Journal of pediatrics.

[73]  G. Lenoir,et al.  Elevated plasma 1,25-dihydroxyvitamin D concentrations in infants with hypercalcemia and an elfin facies. , 1985, The New England journal of medicine.

[74]  J. Haddad,et al.  Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. , 1984, The Journal of clinical investigation.

[75]  B. Hollis,et al.  Evaluation of the total fetomaternal vitamin D relationships at term: evidence for racial differences. , 1984, The Journal of clinical endocrinology and metabolism.

[76]  B. Hollis,et al.  High concentrations of vitamin D2 in human milk associated with pharmacologic doses of vitamin D2. , 1984, The Journal of pediatrics.

[77]  R. Pitkin,et al.  Endocrine regulation of calcium homeostasis during pregnancy. , 1983, Clinics in perinatology.

[78]  N. Bell,et al.  Abnormal regulation of circulating 25-hydroxyvitamin D in the Williams syndrome. , 1982, The New England journal of medicine.

[79]  O. Brooke,et al.  Intrauterine vitamin D nutrition and postnatal growth in Asian infants. , 1981, British medical journal.

[80]  J. Maxwell,et al.  VITAMIN D SUPPLEMENTS ENHANCE WEIGHT GAIN AND NUTRITIONAL STATUS IN PREGNANT ASIANS , 1981, British journal of obstetrics and gynaecology.

[81]  P. D. de Moor,et al.  Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration. , 1981, The Journal of clinical investigation.

[82]  J. Maxwell,et al.  Vitamin D supplements in pregnant Asian women: effects on calcium status and fetal growth. , 1980, British medical journal.

[83]  M. Whitehead,et al.  A PHYSIOLOGICAL ROLE FOR CALCITONIN: PROTECTION OF THE MATERNAL SKELETON , 1979, The Lancet.

[84]  R. Kumar,et al.  Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation. , 1979, The Journal of clinical investigation.

[85]  W. Friedman.  Vitamin D as a cause of the supravalvular aortic stenosis syndrome. , 1967, American heart journal.

[86]  H. Taussig.  Possible injury to the cardiovascular system from vitamin D. , 1966, Annals of internal medicine.

[87]  R. Carter,et al.  ASSOCIATION BETWEEN AORTIC STENOSIS AND FACIES OF SEVERE INFANTILE HYPERCALCAEMIA. , 1963, Lancet.

[88]  Millar Ra,et al.  LYONISATION OF THE X CHROMOSOME. , 1963 .

[89]  T. Moore,et al.  A TEXTBOOK FOR DIETITIANS , 1957 .

[90]  E. Obermer.  Vitamin-D in Pregnancy , 1947 .

[91]  B. Hollis.  Detection of Vitamin D and Its Major Metabolites , 2011 .

[92]  J. Dungan.  Cord-Blood 25-Hydroxyvitamin D Levels and Risk of Respiratory Infection, Wheezing, and Asthma , 2011 .

[93]  L. Laffel,et al.  Significant vitamin D deficiency in youth with type 1 diabetes mellitus. , 2009, The Journal of pediatrics.

[94]  M. Holick,et al.  Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. , 2003, The American journal of clinical nutrition.

[95]  J. Browna,et al.  1 , 25-Dihydroxyvitamin D 3 induces nerve growth factor , promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons , 2003 .

[96]  R. Vieth,et al.  Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. , 2003, The Journal of clinical endocrinology and metabolism.

[97]  F. Dunstan,et al.  Vitamin D deficiency in pregnant women from a non-European ethnic minority population--an interventional study. , 2002, BJOG : an international journal of obstetrics and gynaecology.

[98]  G. Giaccone,et al.  Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. , 2001, Clinical immunology.

[99]  C A Morris,et al.  Williams syndrome and related disorders. , 2000, Annual review of genomics and human genetics.

[100]  its Panel on Folate,et al.  STANDING COMMITTEE ON THE SCIENTIFIC EVALUATION OF DIETARY REFERENCE INTAKES , 1998 .

[101]  V. Lata,et al.  Effects of vitamin D supplementation in pregnancy. , 1981, Gynecologic and obstetric investigation.

[102]  R. Pitkin.  Nutritional influences during pregnancy. , 1977, The Medical clinics of North America.

[103]  E. Obermer.  Vitamin-D requirements in pregnancy. , 1947, British medical journal.